Atlas Trials

Long-term Survivorship Challenges of Advanced/Metastatic GIST Patients Responding to Tyrosine Kinase Inhibitor Treatment: an Observational Study

Clinical trial NCT07522762 · RECRUITING

Trial details

NCT number
NCT07522762
Sponsor
The Netherlands Cancer Institute
Status
RECRUITING
Study type
OBSERVATIONAL
Gastrointenstinal Stromal Tumor (GIST)
Start date
2025-05-21
Primary completion
2027-05-21
Enrollment
330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.